Lattice Biologics (TSXV:LBL.H) Gross-Profit-to-Asset % : 0.00% (As of Jun. 2021)

View and export this data going back to 1995. Start your Free Trial

What is Lattice Biologics Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Lattice Biologics's annualized Gross Profit for the quarter that ended in Jun. 2021 was C$0.00 Mil. Lattice Biologics's average Total Assets over the quarter that ended in Jun. 2021 was C$0.77 Mil. Therefore, Lattice Biologics's annualized Gross-Profit-to-Asset % for the quarter that ended in Jun. 2021 was 0.00%.

Lattice Biologics Gross-Profit-to-Asset % Historical Data

The historical data trend for Lattice Biologics's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lattice Biologics Gross-Profit-to-Asset % Chart

Lattice Biologics Annual Data

Trend

Dec10

Dec11

Dec12

Dec13

Dec14

Sep16

Sep17

Sep18

Sep19

Sep20

Gross-Profit-to-Asset %

Get a 7-Day Free Trial

35.32

13.63

17.13

35.64

38.57

Lattice Biologics Quarterly Data
	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21
Gross-Profit-to-Asset %	Get a 7-Day Free Trial															24.04	30.46	30.46	0.90	-

Competitive Comparison of Lattice Biologics's Gross-Profit-to-Asset %

For the Medical Devices subindustry, Lattice Biologics's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lattice Biologics's Gross-Profit-to-Asset % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Lattice Biologics's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Lattice Biologics's Gross-Profit-to-Asset % falls into.

Lattice Biologics Gross-Profit-to-Asset % Calculation

Lattice Biologics's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Sep. 2020 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (A: Sep. 2020 )	/	( (Total Assets (A: Sep. 2019 )	+	Total Assets (A: Sep. 2020 ))	/ count )
	=	1.351	/	( (3.012	+	3.993)	/ 2 )
	=	1.351	/	3.5025
	=	38.57 %

Lattice Biologics's annualized Gross-Profit-to-Asset % for the quarter that ended in Jun. 2021 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (Q: Jun. 2021 )	/	( (Total Assets (Q: Mar. 2021 )	+	Total Assets (Q: Jun. 2021 ))	/ count )
	=	0	/	( (0.794	+	0.741)	/ 2 )
	=	0	/	0.7675
	=	0.00 %

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Jun. 2021) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

Lattice Biologics Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Lattice Biologics's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

Lattice Biologics (TSXV:LBL.H) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lattice Biologics Ltd (TSXV:LBL.H) » Definitions » Gross-Profit-to-Asset %

Comparable Companies

Traded in Other Exchanges

N/A

Address

512 East Madison Avenue, Suite A1, Belgrade, MT, USA, 59714

Website

http://www.latticebiologics.com

Lattice Biologics Ltd is a biologic product manufacturing company. It manufactures and markets biologic products to domestic and international markets. The products of the company include ADM dermis, DBM Putty, Bone scaffold, and Others, of which key revenue is derived from Bone scaffold. The biologic products are used in various applications such as enhancing fusion in spine surgery, enhancing breast reconstruction post mastectomy for breast cancer patients, sports medicine applications, promotion of bone in foot and ankle surgery, promotion of skull healing following neurosurgery, and subchondral bone defect repair in knee and other joint surgeries. The company generates its revenue from operations principally carried in the United States of America.

Lattice Biologics (TSXV:LBL.H) Headlines

No Headlines